COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,999 Articles (22,627 medRxiv, 8,372 bioRxiv)

Most recent first Previous |  Page 729: Articles 7281-7290  | Next

Persistence of immunity against omicron BA.1 and BA.2 following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-doses AZD1222 vaccination
Assawakosri, S., Kanokudom, S., Chansaenroj, J., Suntronwong, N., Auphimai, C., Nilyanimit, P., Vichaiwattana, P., Thongmee, T., Duangchinda, T., Chantima, W., Pakchotanon, P., Srimuan, D., Thatsanatorn, T., Klinfueng, S., Sudhinaraset, N., Wanlapakorn, N., Mongkolsapaya, J., Honsawek, S., Poovorawan, Y.
10.1101/2022.06.05.22276016 — Posted: 2022-06-06
Understanding COVID-19 admissions in the UK; Analysis of Freedom of Information Requests
Jefferson, T., Brassey, J., Heneghan, C.
10.1101/2022.06.06.22276032 — Posted: 2022-06-06
Predictors of second COVID-19 booster dose or new COVID-19 vaccine hesitancy among nurses: a cross-sectional study
Galanis, P. A., Vraka, I., Katsiroumpa, A., Siskou, O., Konstantakopoulou, O., Katsoulas, T., Mariolis-Sapsakos, T., Kaitelidou, D.
10.1101/2022.06.04.22275989 — Posted: 2022-06-06
Effectiveness of BNT162b2 booster doses in England: an observational study in OpenSAFELY-TPP
Hulme, W. J., Williamson, E. J., Horne, E., Green, A. C., Nab, L., Keogh, R., Parker, E. P., Walker, V. M., Palmer, T. M., Curtis, H. J., Wiedemann, M., Cunningham, C., Walker, A. J., Fisher, L., MacKenna, B., Rentsch, C. T., Schultze, A., Bhaskaran, K., Tazare, J., Tomlinson, L. A., McDonald, H. I., Morton, C. E., Croker, R., Andrews, C. D., Hopcroft, L. E., Park, R. Y., Massey, J., Mehrkar, A., Morley, J., Bacon, S. C., Evans, D., Inglesby, P., Hickman, G., Davy, S., Dillingham, I., Ward, T., Mahalingasivam, V., Zheng, B., Douglas, I. J., Evans, S. J., Bates, C., Sterne, J. A., Hernan, M. A., Goldacre, B.
10.1101/2022.06.06.22276026 — Posted: 2022-06-06
Development and application of an uncapped mRNA platform
Liu, B., Ni, P., Cai, L., Shi, X., Ji, S., Ke, Z., Zhang, S., Hu, B., Yang, B., Xu, Y., Long, W., Fang, Z., Hu, H., Wang, Y., Zhang, W., Geng, H., Xu, Y., Zheng, X., Wang, Z., Zhang, B., Pan, K., Zhou, K., Cui, Y., Wang, H., Liu, B.
10.1101/2022.06.05.494796 — Posted: 2022-06-05
SARS-CoV-2 seroprevalence and living conditions in Bamako (Mali): a cross-sectional multistage household survey after the first epidemic wave, 2020.
Cissoko, M., Landier, J., Kouriba, B., Sangare, A. K., Katile, A., Djimde, A., Berthe, I., Traore, S., Thera, I., Maiga, H., Sogodogo, E., Coulibaly, K., Guindo, A., Dembele, O., Sanogo, S., Doumbia, Z., Dara, C., Altmann, M., Bonnet, E., Balique, H., Sagaon-Teyssier, L., Vidal, L., Sagara, I., Bendiane, M. K., Gaudart, J.
10.1101/2022.06.03.22275924 — Posted: 2022-06-05
A More Accurate Measurement of the Burden of COVID-19 Hospitalizations
Vu, C., Kawaguchi, E. S., Torres, C. H., Lee, A. H., Stafylis, C., Klausner, J. D., Khan, S.
10.1101/2022.06.03.22275891 — Posted: 2022-06-05
Long COVID is associated with extensive in-vivo neuroinflammation on DPA-714 PET
Visser, D., Golla, S. S. V., Verfaillie, S. C. J., Coomans, E. M., Rikken, R. M., van de Giessen, E. M., den Hollander, M. E., Verveen, A., Yaqub, M., Barkhof, F., Horn, J., Koopman, B., Schober, P., Koch, D. W., Schuit, R. C., Windhorst, A. D., Kassiou, M., Boellaard, R., van Vugt, M., Knoop, H., Tolboom, N., van Berckel, B. N. M.
10.1101/2022.06.02.22275916 — Posted: 2022-06-04
An Analysis of PCR Ct Scores and Distributions from the ONS Community Infection Survey during the COVID-19 Second Wave in the UK
Johnson, K., Hammer, S. J., Klymenko, T.
10.1101/2022.06.03.22275903 — Posted: 2022-06-04
COVID-19 Endemic Plan: Impact of Vaccination and Non-pharmaceutical Interventions with Viral Variants and Waning Immunity Using an Agent-Based Simulation
Lee, S., Zabinsky, Z. B., Wasserheit, J. N., Ross, J., Chen, S., Liu, S.
10.1101/2022.06.03.22275834 — Posted: 2022-06-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).